Dr. Jay Bhattacharya, who directs the National Institute of Health, is taking over as acting director of the Centers for Disease Control and Prevention.
Plus: Diving deep into the Medicare Advantage rate kerfuffle. Good afternoon! We’re almost through the week. Let’s get into the Health Brief. Do you have any story tips or health policy intel? Shoot ...
“From Martin Luther King to Barack Obama, there’s a bridge called Jesse Jackson,” the Rev. Al Sharpton said. Jackson, a protégé of the Rev. Martin Luther King Jr. who led the Civil Rights Movement for ...
Medical groups sue to halt CDC vaccine advisory meeting and new child immunization guidelines under Health Secretary RFK Jr. Read more here.
Johnson & Johnson today announced new results from the Phase 1b/2 OrigAMI-4 study showing that first-line treatment with investigational subcutaneous amivantamab and hyaluronidase-lpuj in combination ...
Rev. Jesse Jackson died Tuesday morning at age 84.
Drug observers puzzled by vaccine maker, which made a killing on COVID-19, failing to read the room with new administration. Moderna puts heat on FDA vaccines chief who's already been rebuked once by ...
Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as a ...
Caitlin Donovan, a senior director at the Patient Advocate Foundation, recommends exhausting every available option for ...
National Institutes of Health Director Jay Bhattacharya will step in as acting director of the Centers for Disease Control ...
The co-author of the Great Barrington Declaration, which rebuked CDC’s response to the coronavirus pandemic, will oversee the nation’s leading public health agency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results